Prediction of complication related death after radical cystectomy for bladder cancer with machine learning methodology.

Journal: Scandinavian journal of urology
Published Date:

Abstract

To create a pre-operatively usable tool to identify patients at high risk of early death (within 90 days post-operatively) after radical cystectomy and to assess potential risk factors for post-operative and surgery related mortality. Material consists of 1099 consecutive radical cystectomy (RC) patients operated at 16 different hospitals in Finland 2005-2014. Machine learning methodology was utilized. For model building and testing, the data was randomly divided into training data ( 733, 66.7%) and independent testing data ( 366, 33.3%). To predict the risk of early death after RC from baseline variables, a binary classifier was constructed using logistic regression with lasso regularization. Finally, a user-friendly risk table was constructed for practical use. The model resulted in an area under the receiver operating characteristic curve (AUROC) of 0.73 (95% CI = 0.59-0.87). The strongest risk factors were: American Society of Anesthesiologists physical status classification (ASA), congestive heart failure (CHF), age adjusted Charlson comorbidity index (ACCI) and chronic pulmonary disease. This study with a novel methodological approach adds CHF and chronic pulmonary disease to previously known independent prognostic risk factors for early death after RC. Importantly, the risk prediction tool uses purely pre-operative data and can be used before surgery.

Authors

  • Riku Klén
    Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland.
  • Antti P Salminen
    Department of Urology, Turku University Hospital and University of Turku, Turku, Finland.
  • Mehrad Mahmoudian
    Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland.
  • Kari T Syvänen
    Department of Urology, Turku University Hospital and University of Turku, Turku, Finland.
  • Laura L Elo
    Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland.
  • Peter J Boström
    Department of Urology, Turku University Hospital, Turku, Finland.